RxSight

Forecast & Rating10 analysts currently cover RxSight, with about 10.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $7.57, about 61.9% upside from the current price of $4.68. Price targets range from $5.50 to $11.00 — a wide spread, showing clear disagreement over just how much RxSight can rise. Historically, about 69.4% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on RxSight's outlook. Data as of Sep 23, 2026; for reference only and not investment advice.